Suboxone

Description: 
Images of buprenorphine and buprenorphine/naloxone tablets and film, including Suboxone, Subutex, and generics from various North American manufacturers.
Source: 
Opiate Addiction & Treatment Resource
field_vote: 
Description: 
Prescribing information on Suboxone® sublingual film written by the manufacturers.
Source: 
Reckitt Benckiser
field_vote: 
Tags: 
Description: 
Abbreviated drug review of information relevant to making formulary decisions compiled by PBM. VA experts provided input to content. Manufacturer's information should also be consulted when prescribing buprenorphine/naloxone sublingual film.
Source: 
VHA Pharmacy Benefits Management Services, Medical Advisory Panel, and VISN Pharmacist Executives
field_vote: 
Tags: 
Description: 
The SAMHSA waived physician webboard is a moderated password-protected website in which physicians holding waivers from SAMHSA under the authority of the Drug Addiction Treatment Act of 2000 (DATA 2000) can ask and answer clinical questions about buprenorphine and opioid addiction. Physicians must register and login to access the WebBoard.
Source: 
SAMHSA
field_vote: 
Physician stage in practice: 
Description: 
Patient information sheet on buprenorphine plus naloxone sublingual film
Source: 
Reckitt Benckiser Pharmaceuticals
field_vote: 
Patient Handouts: 
Tags: 
Description: 
PCSS-MAT is a free mentoring service funded by SAMHSA and coordinated by ASAM. The PCSS-MAT can match you with a physician mentor from your local area with whom you can discuss practice and treatment issues with him/her. NOTE: was previously known as PCSS-B for buprenorphine
Source: 
Physician Clinical Support System (PCSS)
field_vote: 
Description: 
Buprenorphine tablets are approved for the treatment of opiate dependence. Buprenorphine treats opiate addiction by preventing symptoms of withdrawal from heroin and other opiates.
Source: 
Food and Drug Administration (FDA)
field_vote: 
Commonly Used Forms: 
Patient Handouts: 

Pages

Subscribe to Suboxone